Compugen (XTAE:CGEN) Cyclically Adjusted Book per Share: ₪3.37 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:CGEN Compugen Ltd XTAE:CGEN
57 GF Score
Price ₪7.24
GF Value ₪15.87
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Compugen Cyclically Adjusted Book per Share?

Compugen XTAE:CGEN +0.67% 57 Cyclically Adjusted Book per Share is ₪3.37 as of Mar. 2026. GuruFocus rates XTAE:CGEN with a GF Score™ of 57/100 and a GF Value™ of ₪15.87 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Compugen's adjusted book value per share for the three months ended in Mar. 2026 was ₪3.074. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₪3.37 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Compugen's average Cyclically Adjusted Book Growth Rate was -7.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -0.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Compugen was 8.70% per year. The lowest was -17.50% per year. And the median was 0.80% per year.

As of today (2026-07-22), Compugen's current stock price is ₪7.237. Compugen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₪3.37. Compugen's Cyclically Adjusted PB Ratio of today is 2.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Compugen was 18.66. The lowest was 0.50. And the median was 3.37.


Compugen  (XTAE:CGEN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Compugen's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=7.237/3.37
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Compugen was 18.66. The lowest was 0.50. And the median was 3.37.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Compugen Cyclically Adjusted Book per Share Related Terms


Compugen Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Compugen's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compugen Cyclically Adjusted Book per Share Chart

Compugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.90 4.24 4.35 3.77 3.40

Compugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.66 3.64 3.52 3.40 3.37

XTAE:CGEN vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Compugen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compugen Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Compugen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Compugen's Cyclically Adjusted PB Ratio falls into.


XTAE:CGEN
57GF Score
Compugen Ltd XTAE:CGEN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compugen Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Compugen's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.074/330.2130*330.2130
=3.074

Current CPI (Mar. 2026) = 330.2130.

Compugen Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.620 241.018 6.330
201609 4.195 241.428 5.738
201612 3.788 241.432 5.181
201703 3.326 243.801 4.505
201706 2.816 244.955 3.796
201709 2.265 246.819 3.030
201712 1.742 246.524 2.333
201803 1.790 249.554 2.369
201806 2.162 251.989 2.833
201809 1.952 252.439 2.553
201812 1.897 251.233 2.493
201903 1.694 254.202 2.201
201906 1.565 256.143 2.018
201909 2.046 256.759 2.631
201912 1.720 256.974 2.210
202003 4.534 258.115 5.800
202006 4.774 257.797 6.115
202009 4.692 260.280 5.953
202012 4.365 260.474 5.534
202103 4.040 264.877 5.037
202106 3.758 271.696 4.567
202109 3.591 274.310 4.323
202112 3.764 278.802 4.458
202203 3.462 287.504 3.976
202206 3.181 296.311 3.545
202209 2.810 296.808 3.126
202212 2.734 296.797 3.042
202303 2.436 301.836 2.665
202306 2.143 305.109 2.319
202309 1.837 307.789 1.971
202312 2.240 306.746 2.411
202403 2.032 312.332 2.148
202406 1.987 314.175 2.088
202409 2.060 315.301 2.157
202412 1.870 315.605 1.957
202503 1.862 319.799 1.923
202506 1.638 322.561 1.677
202509 1.429 324.800 1.453
202512 3.313 324.054 3.376
202603 3.074 330.213 3.074

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₪3.37 mean?
Compugen (XTAE:CGEN) has a Cyclically Adjusted Book per Share of ₪3.37 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Compugen and its competitors.
Is Compugen's Cyclically Adjusted Book per Share too high?
Compugen's current Cyclically Adjusted Book per Share is ₪3.37. Overall, Compugen has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Compugen's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Compugen's Cyclically Adjusted Book per Share of ₪3.37 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Compugen and its competitors. Compugen's current Cyclically Adjusted Book per Share is ₪3.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compugen stock overvalued right now?
Based on GuruFocus' analysis, Compugen (XTAE:CGEN) is currently considered Possible Value Trap. The stock's GF Value™ is ₪15.87, compared to a current price of ₪7.24 — trading 54.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₪3.37. Compugen's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Compugen (XTAE:CGEN), the current Cyclically Adjusted Book per Share is ₪3.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compugen (XTAE:CGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Compugen stock appears to be undervalued. The current stock price of ₪7.24 is trading 54.4% below its estimated GF Value™ of ₪15.87. GuruFocus considers Compugen to be Possible Value Trap.

Key valuation signals for XTAE:CGEN:

  • Cyclically Adjusted Book per Share: ₪3.37
  • GF Value™: ₪15.87 vs. price of ₪7.24 (54.4% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the XTAE:CGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Compugen Business Description

Other Exchanges CGEN:USA
Address 26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
57GF Score

Get the complete analysis for XTAE:CGEN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪7.24
Price
₪15.87
GF Value